Experimental Cancer Treatments Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGEN | D | Agenus Inc. | 3.43 | |
REPL | F | Replimune Group, Inc. | -4.17 | |
GNLX | F | Genelux Corporation | 1.39 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Experimental Cancer Treatments stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.84 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.68 | |
XBI | D | SPDR S&P Biotech ETF | 0.51 | |
ILDR | C | First Trust Innovation Leaders ETF | 0.35 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.3 |
Compare ETFs
Related Industries:
Biotechnology
- Experimental Cancer Treatments
Experimental cancer treatments are treatments that are being tested in clinical trials to determine their safety and effectiveness in treating cancer. These treatments may include new drugs, new combinations of drugs, new surgical procedures, or new ways to use existing treatments.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles